Dolutegravir-based anti-retroviral therapy is effective and safe in HIV–infected paediatric patients

BACKGROUND: Treatment of HIV infection in adolescents is challenging due to long duration of therapy and poor adherence. Recently, the integrase strand transfer inhibitor dolutegravir (DTG) has been approved for the use in adolescents with HIV, but evidence in clinical practice is very limited. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Bruzzese, Eugenia, Lo Vecchio, Andrea, Smarrazzo, Andrea, Tambaro, Orsola, Palmiero, Giulia, Bonadies, Giovanni, Guarino, Alfredo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859652/
https://www.ncbi.nlm.nih.gov/pubmed/29558972
http://dx.doi.org/10.1186/s13052-018-0469-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859652/
https://www.ncbi.nlm.nih.gov/pubmed/29558972
http://dx.doi.org/10.1186/s13052-018-0469-x

Ejemplares similares